semaglutide gastric intestinal obstruction class action in louisiana glp-1 bowel Food-induced small bowel obstruction observed a patient with inappropriate use of Ozempic Gastroparesis Lawsuit Filed Over
Description
They get a new script
Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, not yet licensed by the MHRA or EMA, and currently in Phase 2 and Phase 3 clinical trials
I even tried Ozempic injections
When they do occur, they are typically milder than with standard doses and may include slight nausea or fatigue, which often subsides as your body adjusts
Acta Pharm Sin B, 13(6), 24032424
The difference may partly reflect dose equivalency issues in trials rather than a true pharmacological difference
